Скачать с ютуб Cat-centered Care for Osteoarthritis Patents featuring Veterinary Behaviorist Dr. Margaret Gruen в хорошем качестве

Cat-centered Care for Osteoarthritis Patents featuring Veterinary Behaviorist Dr. Margaret Gruen

Cat-centered Care for Osteoarthritis Patents featuring North Carolina State University’s Veterinary Behaviorist Dr. Margaret Gruen Treating feline osteoarthritis is about to get a whole lot better! Zoetis is launching Solensia, a once-monthly, injectable monoclonal antibody treatment for the control of feline osteoarthritis (OA) pain. Board-certified veterinary behaviorist Margaret Gruen, DVM, PhD, DACVB, joins VerticalVet’s Chief Veterinary Officer, Dr. Ernie Ward, to discuss how your veterinary team can recognize the earliest signs of feline osteoarthritis in your patients. The pair review the subtle signs of pain in cats, tips for what questions to ask cat parents before and during an exam, and clues to spot discomfort when it first begins. This is a wide-ranging discussion on how you can help cat parents identify OA pain in their cat, the role of Solensia in treating pain, and advice on adjunctive and supportive treatments. For more information, visit www.solensiavetteam.com Important Safety Information While the purpose of this discussion is not to dive into the safety and efficacy studies that led to Solensia’s approval, it is nonetheless important to highlight some important safety information. Of note, since NGF is needed for proper neonatal development, Solensia should not be given to pregnant, breeding, or lactating cats. Pregnant women, women trying to conceive, and breastfeeding women should take extreme care to avoid accidental self-injection. For use in cats only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Solensia should not be used in breeding cats or in pregnant or lactating queens. Solensia should not be administered to cats with known hypersensitivity to frunevetmab. The most common adverse events reported in a clinical study were vomiting and injection site pain.